• Healthcare (HC)

    19 Jul 2021

    Erasca IPOs on Nasdaq


EDBI has been part of Erasca's journey since our investment in 2020, and celebrates with the team as their IPO bolsters the company’s war chest and accelerates development of their comprehensive suite of drugs targeting the Ras/MAPK pathway, furthering their mission of erasing cancer.

Read Erasca's press release here:
https://investors.erasca.com/news-releases/news-release-details/erasca-announces-closing-initial-public-offering-and-full


erasca

 

Copyright © 2021 EDBI Pte Ltd